Xin Cai

Title: Xin Cai and PRMT5-Targeted Cancer Research.

Introduction

Xin Cai is an inventor based in Shanghai, China, associated with Innovstone Therapeutics Limited. Her patent work includes research into compounds that inhibit PRMT5, an enzyme target relevant to certain diseases.

Latest Patents

Cai is named on 1 patent, titled “Compound Having Anti-Tumor Activity and Use Thereof.” The patent describes a compound represented by formula (I) that acts as a PRMT5 inhibitor. Reported experiments found inhibitory effects on PRMT5 enzyme activity and tumor cell growth, suggesting potential for treating PRMT5-mediated diseases. The disclosure also presents a synthesis method described as straightforward and suitable for industrial-scale production and application.

Career Highlights

Cai’s listed patent work focuses on medicinal chemistry and the development of potential anti-tumor compounds. The patent connects biological testing with a proposed synthesis approach intended to support further development.

Collaborations

Cai’s named coworkers include Yunlong Song and Wenqing Xu. The patent information identifies this work in connection with Innovstone Therapeutics Limited.

Conclusion

Xin Cai’s patent contribution centers on a proposed PRMT5-inhibiting compound and its potential anti-tumor applications, alongside a synthesis method designed with practical production in mind.